Elevated Risk of Breast Cancer Ends Swedish HRT Trials

Women in Europe Switching to Natural Alternatives Such as Linnea’s Red Clover Extract IFL40

The February 7th issue of The Lancet noted that Swedish researchers have discontinued HRT trials in breast cancer survivors after preliminary results suggested a link between HRT and an increased risk in cancer recurrence. This result follows results in other experiments such as the Women’s Health Initiative which was also discontinued in 2002.

As a result of this discontinuation, many women in Europe are switching to clinically proven natural alternatives such as Red Clover extract IFL40.

Visit LINNEA at Natural Products Expo West
BOOTH #1625, HALL B, MARCH 4-7, 2004

For more informationon IFL40, visit www.linnea-worldwide.com, or e-mail dstanek@linnea-worldwide.com

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.